Trial intelligence / Profile preview

IV Lidocaine for Post-Operative Pain in Staging Laparoscopy

NCT07419815Active, not recruiting

Sponsor
Shaukat Khanum Memorial Cancer Hospital & Research Centre
Start
Dec 2025
Primary completion
Aug 2026
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in postoperative pain comparing Group A (Lidocaine) with Group B (Placebo) (2 arms). Primary endpoint: Mean pain score at 2 hours. Started Dec 2025; status: active, not recruiting.

02

Drugs

Lidocaine Hydrochloride Injection, without epinephrine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT07419815.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07419815.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call